Mucosal lipocalin 2 has pro-inflammatory and iron-sequestering effects in response to bacterial enterobactin

PLoS Pathogens

Volumn 5, Issue 10, 2009, Pages

  Bachman, Michael A ^a   Miller, Virginia L ^b   Weiser, Jeffrey N ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; ENTEROCHELIN; IRON; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; YERSINIABACTIN; ACUTE PHASE PROTEIN; AUTACOID; LCN2 PROTEIN, MOUSE; LIPOCALIN; ONCOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM MUTANT; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; GENE; GENE LOCUS; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLAMMATION; IROA GENE; KLEBSIELLA PNEUMONIAE; MICROBIAL METABOLISM; MOUSE; NEUTROPHIL; NONHUMAN; NOSE; NUCLEOTIDE SEQUENCE; PREDICTION; PROTEIN BINDING; PROTEIN INTERACTION; RESPIRATORY TRACT MUCOSA; ANIMAL; BACTERIUM; C57BL MOUSE; CELL CULTURE; CELL PROLIFERATION; CHEMICALLY INDUCED DISORDER; CHEMISTRY; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; MUCOSAL IMMUNITY; PHYSIOLOGY;

BACTERIA (MICROORGANISMS); ENTEROBACTERIACEAE; KLEBSIELLA PNEUMONIAE; MURINAE; NEGIBACTERIA; POSIBACTERIA;

ACUTE-PHASE PROTEINS; ANIMALS; BACTERIA; CELL PROLIFERATION; CELLS, CULTURED; ENTEROBACTIN; HUMANS; IMMUNITY, MUCOSAL; INFLAMMATION; INFLAMMATION MEDIATORS; IRON; KLEBSIELLA PNEUMONIAE; LIPOCALINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; ONCOGENE PROTEINS; PROTEIN BINDING; RESPIRATORY MUCOSA;

EID: 73449084865     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1000622     Document Type: Article

References (41)

1. Earhart CF (1996) Uptake and Metabolism of Iron and Molybdenum. In: Neidhart F, ed. E coli and Salmonella: ASM Press.
2. Goetz DH, Holmes MA, Borregaard N, Bluhm ME, Raymond KN, et al. (2002) The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol Cell 10: 1033-1043.
3. Flo TH, Smith KD, Sato S, Rodriguez DJ, Holmes MA, et al. (2004) Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 432: 917-921.
4. Friedl A, Stoesz SP, Buckley P, Gould MN (1999) Neutrophil gelatinaseassociated lipocalin in normal and neoplastic human tissues. Cell type-specific pattern of expression. Histochem J 31: 433-441.
5. Kjeldsen L, Bainton DF, Sengelov H, Borregaard N (1994) Identification of neutrophil gelatinase-associated lipocalin as a novel matrix protein of specific granules in human neutrophils. Blood 83: 799-807.
6. Nelson AL, Barasch JM, Bunte RM, Weiser JN (2005) Bacterial colonization of nasal mucosa induces expression of siderocalin, an iron-sequestering component of innate immunity. Cell Microbiol 7: 1404-1417.
7. Devireddy LR, Gazin C, Zhu X, Green MR (2005) A cell-surface receptor for lipocalin 24p3 selectively mediates apoptosis and iron uptake. Cell 123: 1293-1305.
8. Nelson AL, Ratner AJ, Barasch J, Weiser JN (2007) Interleukin-8 secretion in response to aferric enterobactin is potentiated by siderocalin. Infect Immun 75: 3160-3168.
9. Koczura R, Kaznowski A (2003) Occurrence of the Yersinia high-pathogenicity island and iron uptake systems in clinical isolates of Klebsiella pneumoniae. Microb Pathog 35: 197-202.
10. Schubert S, Cuenca S, Fischer D, Heesemann J (2000) High-pathogenicity island of Yersinia pestis in Enterobacteriaceae isolated from blood cultures and urine samples: prevalence and functional expression. J Infect Dis 182: 1268-1271.
11. Strong R (2005) Siderocalins. In: Akerstrom B, Borregaard N, Flower DR, Salier J, eds. Lipocalins. Austin: Landes Bioscience.
12. Baumler AJ, Norris TL, Lasco T, Voight W, Reissbrodt R, et al. (1998) IroN, a novel outer membrane siderophore receptor characteristic of Salmonella enterica. J Bacteriol 180: 1446-1453.
13. Baumler AJ, Tsolis RM, van der Velden AW, Stojiljkovic I, Anic S, et al. (1996) Identification of a new iron regulated locus of Salmonella typhi. Gene 183: 207-213.
14. Chen YT, Chang HY, Lai YC, Pan CC, Tsai SF, et al. (2004) Sequencing and analysis of the large virulence plasmid pLVPK of Klebsiella pneumoniae CG43. Gene 337: 189-198.
15. Dobrindt U, Blum-Oehler G, Hartsch T, Gottschalk G, Ron EZ, et al. (2001) SFimbria-encoding determinant sfa(I) is located on pathogenicity island III(536) of uropathogenic Escherichia coli strain 536. Infect Immun 69: 4248-4256.
16. Foster JW, Hall HK (1992) Effect of Salmonella typhimurium ferric uptake regulator (fur) mutations on iron- and pH-regulated protein synthesis. J Bacteriol 174: 4317-4323.
17. Hsieh PF, Lin TL, Lee CZ, Tsai SF, Wang JT (2008) Serum-induced ironacquisition systems and TonB contribute to virulence in Klebsiella pneumoniae causing primary pyogenic liver abscess. J Infect Dis 197: 1717-1727.
18. Fischbach MA, Lin H, Liu DR, Walsh CT (2006) How pathogenic bacteria evade mammalian sabotage in the battle for iron. Nat Chem Biol 2: 132-138.
19. Fischbach MA, Lin H, Zhou L, Yu Y, Abergel RJ, et al. (2006) The pathogenassociated iroA gene cluster mediates bacterial evasion of lipocalin 2. Proc Natl Acad Sci U S A 103: 16502-16507.
20. Crouch ML, Castor M, Karlinsey JE, Kalhorn T, Fang FC (2008) Biosynthesis and IroC-dependent export of the siderophore salmochelin are essential for virulence of Salmonella enterica serovar Typhimurium. Mol Microbiol 67: 971-983.
21. Podschun R, Ullmann U (1998) Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev 11: 589-603.
22. Lawlor MS, O'Connor C, Miller VL (2007) Yersiniabactin is a virulence factor for Klebsiella pneumoniae during pulmonary infection. Infect Immun 75: 1463-1472.
23. Lawlor MS, Hsu J, Rick PD, Miller VL (2005) Identification of Klebsiella pneumoniae virulence determinants using an intranasal infection model. Mol Microbiol 58: 1054-1073.
24. McCool TL, Weiser JN (2004) Limited role of antibody in clearance of Streptococcus pneumoniae in a murine model of colonization. Infect Immun 72: 5807-5813.
25. Relman DA, Falkow S (2005) Principles and Practice of Infectious Diseases. In: Mandell GL, ed. Principles and Practice of Infectious Diseases. Philadelphia: Elsevier. pp 3-4.
26. Yancey RJ, Breeding SA, Lankford CE (1979) Enterochelin (enterobactin): virulence factor for Salmonella typhimurium. Infect Immun 24: 174-180.
27. Caza M, Lepine F, Milot S, Dozois CM (2008) Specific roles of the iroBCDEN genes in virulence of an avian pathogenic Escherichia coli O78 strain and in production of salmochelins. Infect Immun 76: 3539-3549.
28. Elidemir O, Fan LL, Colasurdo GN (2000) A novel diagnostic method for pulmonary aspiration in a murine model. Immunocytochemical staining of milk proteins in alveolar macrophages. Am J Respir Crit Care Med 161: 622-626.
29. Raphael GD, Jeney EV, Baraniuk JN, Kim I, Meredith SD, et al. (1989) Pathophysiology of rhinitis. Lactoferrin and lysozyme in nasal secretions. J Clin Invest 84: 1528-1535.
30. Wooldridge KG, Williams PH (1993) Iron uptake mechanisms of pathogenic bacteria. FEMS Microbiol Rev 12: 325-348.
31. Raffatellu M, George MD, Akiyama Y, Hornsby MJ, Nuccio SP, et al. (2009) Lipocalin-2 resistance confers an advantage to Salmonella enterica serotype Typhimurium for growth and survival in the inflamed intestine. Cell Host Microbe 5: 476-486.
32. Abergel RJ, Wilson MK, Arceneaux JE, Hoette TM, Strong RK, et al. (2006) Anthrax pathogen evades the mammalian immune system through stealth siderophore production. Proc Natl Acad Sci U S A 103: 18499-18503.
33. Rao VK, Krasan GP, Hendrixson DR, Dawid S, St Geme JW, 3rd (1999) Molecular determinants of the pathogenesis of disease due to non-typable Haemophilus influenzae. FEMS Microbiol Rev 23: 99-129.
34. Tai SS, Lee CJ, Winter RE (1993) Hemin utilization is related to virulence of Streptococcus pneumoniae. Infect Immun 61: 5401-5405.
35. Jeyaseelan S, Manzer R, Young SK, Yamamoto M, Akira S, et al. (2005) Induction of CXCL5 during inflammation in the rodent lung involves activation of alveolar epithelium. Am J Respir Cell Mol Biol 32: 531-539.
36. Kobayashi Y (2006) Neutrophil infiltration and chemokines. Crit Rev Immunol 26: 307-316.
37. Standiford TJ, Tsai WC, Mehrad B, Moore TA (2000) Cytokines as targets of immunotherapy in bacterial pneumonia. J Lab Clin Med 135: 129-138.
38. Chan YR, Liu JS, Pociask DA, Zheng M, Mietzner TA, et al. (2009) Lipocalin 2 is required for pulmonary host defense against Klebsiella infection. J Immunol 182: 4947-4956.
39. Miller VL, Mekalanos JJ (1988) A novel suicide vector and its use in construction of insertion mutations: osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR. J Bacteriol 170: 2575-2583.
40. Yang J, Goetz D, Li JY, Wang W, Mori K, et al. (2002) An iron delivery pathway mediated by a lipocalin. Mol Cell 10: 1045-1056.
41. Fischbach MA, Lin H, Liu DR, Walsh CT (2005) In vitro characterization of IroB, a pathogen-associated C-glycosyltransferase. Proc Natl Acad Sci U S A 102: 571-576.